FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

385114002: Prolonged-release transdermal patch (dose form)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3634738017 Prolonged-release transdermal patch (dose form) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3634739013 Prolonged-release transdermal patch en Synonym Active Entire term case insensitive SNOMED CT core module
106069801000001110 Transdermal patch en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Prolonged-release transdermal patch Is a Cutaneous AND/OR transdermal dosage form false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Drug patch false Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form intended site Transdermal true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Is a Transdermal dose form true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form administration method Apply true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form transformation No transformation true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has dose form release characteristic Prolonged-release true Inferred relationship Existential restriction modifier
Prolonged-release transdermal patch Has basic dose form Patch true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Durogesic DTrans 50micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Pilsco Ltd) 24 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Ethigen Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (Ethigen Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Ethigen Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Pilsco Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (Ethigen Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Pilsco Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 10 transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (Pilsco Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Pilsco Ltd) 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Pilsco Ltd) 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transiderm-Nitro 5 transdermal patches (Pilsco Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel 50 patches (Pilsco Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Almuriva 13.3mg/24hours transdermal patches (Sandoz Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm 1.5mg patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (CST Pharma Ltd) 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (CST Pharma Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (CST Pharma Ltd) 6 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi 50micrograms/24hours Phase 1 patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Scopoderm 1.5mg patches (Pilsco Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Sequi Phase 2 patches (CST Pharma Ltd) 2 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 25micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 12micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 100micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 12micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 75micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Opiodur 50micrograms/hour transdermal patches (Zentiva Pharma UK Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Kentera 3.9mg/24hours patches (Pharmaram Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Kentera 3.9mg/24hours patches (Pharmaram Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Alzest 13.3mg/24hours transdermal patches (Dr Reddy's Laboratories (UK) Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (Pilsco Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (Pilsco Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (CST Pharma Ltd) 8 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Evorel Conti patches (CST Pharma Ltd) 24 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 12micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 75micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 100micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 50micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Durogesic DTrans 25micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 20micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
BuTrans 20micrograms/hour transdermal patches (Mawdsley-Brooks & Company Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 12micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (CST Pharma Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 25micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 12micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 52.5micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (CST Pharma Ltd) 12 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 75micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 25micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 35micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
FemSeven Conti patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 50micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Transtec 70micrograms/hour transdermal patches (CST Pharma Ltd) 4 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (CST Pharma Ltd) 5 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Matrifen 100micrograms/hour transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (CST Pharma Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (CST Pharma Ltd) 30 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 4.6mg/24hours transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Exelon 9.5mg/24hours transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (CST Pharma Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 2mg/24hours transdermal patches (CST Pharma Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (CST Pharma Ltd) Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 4mg/24hours transdermal patches (CST Pharma Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 8mg/24hours transdermal patches (CST Pharma Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (CST Pharma Ltd) 7 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier
Neupro 6mg/24hours transdermal patches (CST Pharma Ltd) 28 patch Has dispensed dose form True Prolonged-release transdermal patch Inferred relationship Existential restriction modifier

Start Page 2 of 21 Next End

This concept is not in any reference sets

Back to Start